EPT Chart Discussion, page-50

Yeah lets not get too carried away lol RAP is going to be more than disruptive when it gets FDA approval make no mistake and it solves a completely different health issue to EPAT. Actually RAP did make the news last year in a short segment so for EPT to gain this sort of media attention bodes well and the similarities continue. EPT at $25m market cap compared to peers is still extremely cheap versus the potential contracts that will ensue once approvals are in place (and i believe they are in a good position to get them).